Safety and Efficacy Study of QL0911 to Treat Immune Thrombocytopenia (ITP) in Pediatric Patients
Clinical trial NCT07455006 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07455006
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-20
- Primary completion
- 2027-12-10
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.